Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 10-KT Annual report (with FYE transition)
- 10.5 Code of Business Conduct and Ethics
- 10.6 Form of Incentive Stock Option Award Agreement
- 10.7 Form of Non-qualified Stock Option Award Agreement
- 10.8 Form of Restricted Stock Award Agreement
- 10.9 Form of Restricted Stock Unit Award Agreement
- 10.10 Form of Stock Appreciation Rights Award Agreement
- 10.11 Form of Indemnification Agreement
- 21 Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification Pursuant to Rule 13A-14 of the Securities Exchange Act of 1934
- 31.2 Certification Pursuant to Rule 13A-14 of the Securities Exchange Act of 1934
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-251261 on Form S-3 of our report dated March 2, 2021 (which includes an explanatory paragraph regarding Mosaic ImmunoEngineering Inc.’s ability to continue as a going concern), relating to the consolidated financial statements of Mosaic ImmunoEngineering Inc. (formerly Patriot Scientific Corporation) and subsidiaries, appearing in this Transition Report on Form 10-K of Mosaic ImmunoEngineering Inc. for the seven months ended December 31, 2020.
/s/ KMJ Corbin & Company LLP
Irvine, California
March 2, 2021